RC220 is already undergoing the toxicology testing. Thankfully we are able to use the engineering scale batch that was produced and announced last year for the GLP studies and not have to wait for the GMP RC220 to be delivered. This saves about 6 months off the timeline.
RC220 remains on track for delivery in Q1, but of course until it arrives anything could happen. I am not worried about RC220, my worries are directed towards the GLP toxicology studies as any delay in these studies (there are something like 26 separate studies involved) will be what delays us getting back into the clinic.
General Comments / Chat, page-10730
-
- There are more pages in this discussion • 283 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
-0.140(7.61%) |
Mkt cap ! $289.4M | |||
| Open | High | Low | Value | Volume |
| $1.88 | $1.89 | $1.70 | $456.4K | 259.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.70 | 8662 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |